Literature DB >> 8564984

Activation of stress-activator protein kinase/c-Jun N-terminal kinase by the non-TPA-type tumor promoter palytoxin.

D W Kuroki1, G S Bignami, E V Wattenberg.   

Abstract

Previous studies have shown that structurally diverse tumor promoters can modulate protein kinases involved in signal transduction. In this study, we show that palytoxin, a potent non-12-O-tetradecanoylphorbol-13-acetate (TPA)-type skin tumor promoter, induces a signaling pathway leading to the activation of the stress-activated protein kinases/c-Jun N-terminal kinases (JNK) in Swiss 3T3 fibroblasts. Treatment of cells with doses as low as 0.1 mN palytoxin results in significant activation of JNK. In contrast to epidermal growth factor, which induces a transient activation of JNK in Swiss 3T3 cells, palytoxin causes prolonged enzyme activation. Since stimulation of ion flux appears to play an important role in the mechanism of action of palytoxin in other systems, we investigated the role of sodium and calcium in the activation of JNK: (a) our results show that incubation of Swiss 3T3 cells in a sodium-free medium dramatically reduced the magnitude of JNK activation by palytoxin; and (b) we found that the sodium ionophore gramicidin activates JNK. Together, these results suggest that sodium influx, which is a hallmark of palytoxin action, may play a key role in the activation of JNK by palytoxin. Our results indicate that calcium influx is not necessary or sufficient for palytoxin-induced activation of JNK. In contrast to palytoxin, the TPA-type tumor promoter phorbol 12,13-dibutyrate and the non-TPA-type tumor promoters thapsigargin and okadaic acid do not appear to activate JNK in this system. In contrast to phorbol 12,13-dibutyrate, palytoxin does not activate the p42/p44 mitogen-activated protein kinases. Our results demonstrate that Swiss 3T3 fibroblasts, palytoxin can activate a protein kinase signaling pathway that is distinct from that activated by the prototypical phorbol ester tumor promoters and other potent skin tumor promoters.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8564984

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

Review 1.  Modulation of protein kinase signaling cascades by palytoxin.

Authors:  Elizabeth V Wattenberg
Journal:  Toxicon       Date:  2010-11-09       Impact factor: 3.033

2.  Ribotoxic stress response: activation of the stress-activated protein kinase JNK1 by inhibitors of the peptidyl transferase reaction and by sequence-specific RNA damage to the alpha-sarcin/ricin loop in the 28S rRNA.

Authors:  M S Iordanov; D Pribnow; J L Magun; T H Dinh; J A Pearson; S L Chen; B E Magun
Journal:  Mol Cell Biol       Date:  1997-06       Impact factor: 4.272

Review 3.  Palytoxin: exploiting a novel skin tumor promoter to explore signal transduction and carcinogenesis.

Authors:  Elizabeth V Wattenberg
Journal:  Am J Physiol Cell Physiol       Date:  2006-07-19       Impact factor: 4.249

4.  Extracellular signal regulated kinase 5 mediates signals triggered by the novel tumor promoter palytoxin.

Authors:  Aaron T Charlson; Nicholette A Zeliadt; Elizabeth V Wattenberg
Journal:  Toxicol Appl Pharmacol       Date:  2009-08-28       Impact factor: 4.219

5.  Proteomic Studies of the Mechanism of Cytotoxicity, Induced by Palytoxin on HaCaT Cells.

Authors:  Dingyuan Cheng; Bowen Deng; Qiling Tong; Siyi Gao; Boyi Xiao; Mengxuan Zhu; Ziyu Ren; Lianghua Wang; Mingjuan Sun
Journal:  Toxins (Basel)       Date:  2022-04-10       Impact factor: 5.075

6.  Head and neck cancer cells and xenografts are very sensitive to palytoxin: decrease of c-jun n-terminale kinase-3 expression enhances palytoxin toxicity.

Authors:  Tibor Görögh; László Bèress; Elgar S Quabius; Petra Ambrosch; Markus Hoffmann
Journal:  Mol Cancer       Date:  2013-02-14       Impact factor: 27.401

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.